Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $9.38M by Medicaid between Jan 2018 and Dec 2024, across 211 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
SANTA CLARA, CA 95051
SANTA CLARA, CA 95051
33aNPI1326119967assigned 11/13/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.38M
24GClaims680,613
24DCodes billed211
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#185 of 410
Median peer was paid$6.90M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,109 | $197K | |
| 2019 | 70,291 | $222K | |
| 2020 | 69,140 | $262K | |
| 2021 | 101,000 | $428K | |
| 2022 | 126,881 | $496K | |
| 2023 | 138,004 | $629K | |
| 2024incomplete | 133,188 | $7.14M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 11,491 | 10,749 | $1.75M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 7,226 | 7,034 | $975K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9.3% | 10,835 | 10,545 | $876K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 3,341 | 3,187 | $576K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 5.3% | 1,223 | 1,211 | $496K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.0% | 4,872 | 4,793 | $466K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.1% | 8,040 | 7,784 | $286K |
| G0378 | Hospital observation service, per hour | 3.0% | 3,022 | 2,514 | $279K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.9% | 5,803 | 5,690 | $274K |
| 0450 | Emergency room services | 2.9% | 14,753 | 13,308 | $270K |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 9,562 | 9,297 | $241K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 5,315 | 5,159 | $175K |
199 more codes
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.4% | 4,508 | $131K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.1% | 1,526 | $106K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.1% | 1,684 | $99K |
| 76830 | Ultrasound, transvaginal | 1.0% | 2,562 | $95K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.0% | 763 | $95K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 2,034 | $84K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 13,726 | $84K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,169 | $81K |
| 72141 | <1% | 674 | $68K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,290 | $67K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,825 | $67K |
| 99199 | Unlisted special service, procedure or report | <1% | 1,402 | $66K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,291 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 41,210 | $57K |
| 73630 | <1% | 2,417 | $56K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,886 | $56K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,289 | $52K |
| 36415 | Collection of venous blood by venipuncture | <1% | 37,679 | $49K |
| 86900 | <1% | 3,258 | $47K | |
| 73564 | <1% | 1,292 | $46K | |
| 73030 | <1% | 2,006 | $39K | |
| 76770 | <1% | 1,054 | $39K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 632 | $38K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 265 | $37K |
| 73130 | <1% | 1,634 | $34K | |
| 0270 | <1% | 7,430 | $34K | |
| 73610 | <1% | 1,598 | $33K | |
| 72100 | <1% | 1,362 | $32K | |
| 83880 | <1% | 6,627 | $31K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 255 | $31K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,059 | $31K |
| 80051 | <1% | 22,888 | $29K | |
| 71250 | <1% | 819 | $28K | |
| 93971 | <1% | 701 | $28K | |
| 73560 | <1% | 1,345 | $25K | |
| 86850 | <1% | 3,048 | $25K | |
| 86923 | <1% | 230 | $24K | |
| 82565 | <1% | 28,675 | $23K | |
| 74018 | <1% | 801 | $22K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 433 | $21K |
| 76536 | <1% | 608 | $20K | |
| 73110 | <1% | 952 | $18K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,469 | $18K |
| 73502 | <1% | 801 | $17K | |
| 82247 | <1% | 18,239 | $17K | |
| 84460 | <1% | 18,144 | $16K | |
| 70486 | <1% | 340 | $16K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 722 | $16K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 3,079 | $16K |
| 84484 | <1% | 9,095 | $14K | |
| 86901 | <1% | 3,259 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,232 | $14K |
| 82947 | <1% | 22,984 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,036 | $14K |
| 84702 | <1% | 3,391 | $14K | |
| 84450 | <1% | 14,972 | $14K | |
| 84520 | <1% | 22,726 | $14K | |
| 70543 | <1% | 26 | $14K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,759 | $13K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 384 | $13K |
| 83690 | <1% | 10,349 | $13K | |
| 73080 | <1% | 380 | $13K | |
| 73140 | <1% | 400 | $12K | |
| 81001 | <1% | 19,851 | $11K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 10,323 | $10K |
| 83735 | <1% | 9,639 | $10K | |
| 84075 | <1% | 11,824 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,459 | $10K |
| J3490 | Unclassified drugs | <1% | 3,583 | $10K |
| 76857 | <1% | 252 | $9K | |
| 72040 | <1% | 222 | $9K | |
| 0637 | <1% | 42,969 | $8K | |
| 93976 | <1% | 462 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,269 | $8K |
| 73562 | <1% | 263 | $7K | |
| 84703 | <1% | 6,424 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 591 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,451 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 592 | $6K |
| 85610 | <1% | 9,076 | $6K | |
| 76870 | <1% | 62 | $6K | |
| 87631 | <1% | 507 | $6K | |
| 72146 | <1% | 41 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,215 | $5K |
| 59025 | Fetal non-stress test | <1% | 330 | $5K |
| 81003 | <1% | 12,953 | $5K | |
| 85652 | <1% | 6,884 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,837 | $5K |
| 83605 | <1% | 3,097 | $5K | |
| 87040 | <1% | 2,283 | $4K | |
| Z7502 | <1% | 368 | $4K | |
| 74170 | <1% | 13 | $4K | |
| 82248 | <1% | 2,385 | $4K | |
| 84100 | <1% | 5,366 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 38 | $4K |
| 73221 | <1% | 29 | $4K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 364 | $3K |
| 0250 | <1% | 6,441 | $3K | |
| 80306 | <1% | 1,100 | $3K | |
| 82310 | <1% | 2,443 | $3K | |
| 82077 | <1% | 1,176 | $3K | |
| 87324 | <1% | 873 | $3K | |
| 87449 | <1% | 892 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,010 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,024 | $3K |
| 70491 | <1% | 24 | $3K | |
| 84132 | <1% | 2,829 | $3K | |
| 87088 | <1% | 2,824 | $3K | |
| 73590 | <1% | 109 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,635 | $2K |
| 76882 | <1% | 27 | $2K | |
| 85027 | <1% | 2,509 | $2K | |
| 82962 | <1% | 3,915 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 42 | $2K |
| 86140 | <1% | 1,495 | $2K | |
| 96376 | <1% | 878 | $2K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 796 | $2K |
| 85730 | <1% | 1,449 | $2K | |
| 84295 | <1% | 1,796 | $2K | |
| 82570 | <1% | 597 | $2K | |
| 80179 | <1% | 746 | $2K | |
| 82040 | <1% | 1,172 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 607 | $2K |
| 85379 | <1% | 893 | $1K | |
| 0710 | <1% | 2,223 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,149 | $1K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 213 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 131 | $1K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,272 | $1K |
| 84156 | <1% | 465 | $980.30 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,190 | $978.93 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 132 | $958.89 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 755 | $659.65 |
| 74019 | <1% | 12 | $613.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 760 | $556.77 |
| 73660 | <1% | 27 | $534.98 | |
| 82803 | <1% | 152 | $511.36 | |
| 85378 | <1% | 292 | $421.44 | |
| 86780 | <1% | 92 | $402.07 | |
| J1815 | Injection, insulin, per 5 units | <1% | 749 | $347.57 |
| 99070 | <1% | 25 | $340.75 | |
| 87205 | <1% | 313 | $253.16 | |
| C1769 | Guide wire | <1% | 145 | $253.05 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,108 | $244.83 |
| 82550 | <1% | 367 | $240.68 | |
| 83615 | <1% | 203 | $223.60 | |
| 90715 | <1% | 57 | $194.19 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 17 | $185.28 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 193 | $163.87 |
| 0636 | <1% | 29 | $156.79 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 85 | $149.06 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 223 | $131.80 |
| 0370 | <1% | 2,034 | $128.33 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 109 | $123.42 |
| 73090 | <1% | 45 | $119.84 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $113.78 |
| 85007 | <1% | 565 | $103.83 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 241 | $93.84 |
| 86803 | <1% | 13 | $92.59 | |
| 82140 | <1% | 13 | $90.00 | |
| 82150 | <1% | 12 | $82.00 | |
| 87081 | <1% | 40 | $68.61 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 555 | $66.96 |
| 82272 | <1% | 36 | $61.00 | |
| 87070 | <1% | 41 | $52.58 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 410 | $51.38 |
| 12001 | <1% | 39 | $48.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 925 | $46.49 |
| 90686 | <1% | 14 | $31.92 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 73 | $31.52 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 131 | $30.18 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 14 | $25.95 |
| 97162 | <1% | 27 | $25.05 | |
| 82728 | <1% | 18 | $25.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $24.39 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 22 | $23.46 |
| 72170 | <1% | 14 | $22.95 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 15 | $22.77 |
| 85018 | <1% | 27 | $14.92 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 17 | $14.92 |
| 85014 | <1% | 27 | $14.92 | |
| 84550 | <1% | 12 | $6.00 | |
| 0258 | 0% | 476 | $0.00 | |
| 0990 | 0% | 124 | $0.00 | |
| 85008 | 0% | 43 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 0% | 52 | $0.00 |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 27 | $0.00 |
| 80329 | 0% | 16 | $0.00 | |
| 88304 | 0% | 25 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 56 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| 76376 | 0% | 188 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 42 | $0.00 |
| 89055 | 0% | 28 | $0.00 | |
| 96367 | 0% | 12 | $0.00 | |
| 0272 | 0% | 70 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 12 | $0.00 |
| 76775 | 0% | 12 | $0.00 | |
| 90749 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOYD, CHRISTOPHER (SENIOR VICE PRESIDENT, AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | Santa Clara, CA | $751K |
| Kaiser Foundation Hospitals | Santa Clara, CA | $735K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.